NovoTech Patent Firm Attorneys Recognized Again as Super Lawyers in 2025 NovoTech Patent Firm's Babak Akhlaghi and Steve Becker have been recognized as Super Lawyers for their excellence in intellectual property law, showcasing their dedication and expertise.

NovoTech Patent Firm Attorneys Recognized Again as Super Lawyers in 2025 #United_States #Washington #NovoTech #Super_Lawyers #Babak_Akhlaghi

Ten Years of Innovation and Impact: Celebrating NovoTech Patent Firm's Anniversary NovoTech Patent Firm marks a significant milestone with its 10-year anniversary, reflecting on a decade of innovative achievements and client success.

Ten Years of Innovation and Impact: Celebrating NovoTech Patent Firm's Anniversary #United_States #Washington #NovoTech #Patent_Firm #Babak_Akhlaghi

Novotech Recognized as 2025 Global Company of the Year in Biotech Clinical Research Excellence Novotech has received outstanding recognition as the 2025 Global Company of the Year by Frost & Sullivan, affirming its leadership in biotech clinical research services.

Novotech Recognized as 2025 Global Company of the Year in Biotech Clinical Research Excellence #USA #biotech #San_Antonio #Clinical_Research #NovoTech

NovoTech Patent Firm Showcases Client Innovations at CES 2025 NovoTech Patent Firm highlights client innovations at CES 2025, exploring cutting-edge tech trends like AI, quantum computing, and sustainable solutions.

NovoTech Patent Firm Showcases Client Innovations at CES 2025 #United_States #CES_2025 #Washington,_DC #Intellectual_Property #NovoTech

Sen-Jam Pharmaceutical Partners with 5 Horizons Capital to Revolutionize Clinical Trials for SJP-001 Sen-Jam Pharmaceutical announces a strategic partnership with 5 Horizons Capital to finance its SJP-001 clinical trials, targeting inflammation management. The collaboration promises innovative solutions in metabolic health.

Sen-Jam Pharmaceutical Partners with 5 Horizons Capital to Revolutionize Clinical Trials for SJP-001 #United_States #Huntington #NovoTech #Sen-Jam_Pharmaceutical #SJP-001

Sen-Jam Pharmaceutical Achieves Ethics Approval for SJP-001 Clinical Trials in Australia Sen-Jam Pharmaceutical has secured ethics approval for SJP-001 clinical trials in Australia, targeting inflammation and metabolic health through innovative therapies.

Sen-Jam Pharmaceutical Achieves Ethics Approval for SJP-001 Clinical Trials in Australia #Australia #Huntington #NovoTech #Sen-Jam #SJP-001

NovoTech Patent Firm Engages NC State Engineering Students in Innovative Career Exploration Event NovoTech Patent Firm hosted NC State engineering students for a dynamic career exploration event that expanded their horizons beyond traditional engineering paths, highlighting patent law.

NovoTech Patent Firm Engages NC State Engineering Students in Innovative Career Exploration Event #United_States #Washington #Patent_Law #NovoTech #NC_State